Biorelate

About:

Biorelate provides biomedical research services.

Top Investors: Triple Point Ventures, Maven Capital Partners, YFM Equity Partners, Northern Powerhouse Investment Fund, Catapult Ventures

Description:

Biorelate provides biomedical research services. It engages in the research of biomarkers for the diagnosis of prostate cancer; target validation; and new drug development services. Daniel Jamison founded Biorelate in 2014. It has its headquarters in Oldham in the United Kingdom.

Total Funding Amount:

7.3M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Oldham, Oldham, United Kingdom

Founded Date:

2014-01-01

Contact Email:

info(AT)biorelate.com

Founders:

Daniel Jamieson

Number of Employees:

11-50

Last Funding Date:

2022-11-29

IPO Status:

Private

Industries: